Institute of Chemistry, Technology and Metallurgy, University of Belgrade, Belgrade, Serbia.
Planta Med. 2013 Apr;79(6):499-505. doi: 10.1055/s-0032-1328301. Epub 2013 Mar 19.
A study of secondary metabolites from the bark of Alnus glutinosa led to the isolation of fourteen diarylheptanoids: oregonin (1), platyphylloside (2), rubranoside A (3), rubranoside B (4), hirsutanonol (5), hirsutenone (6), hirsutanonol-5-O-β-D-glucopyranoside (7), platyphyllonol-5-O-β-D-xylopyranoside (8), aceroside VII (9), alnuside A (10), alnuside B (11), 1,7-bis-(3,4-dihydoxyphenyl)-5-hydroxy-heptane-3-O-β-D-xylopyranoside (12), (5S)-1-(4-hydroxyphenyl)-7-(3,4-dihydroxyphenyl)-5-O-β-D-glucopyranosyl-heptan-3-one (13), and (5S)-1,7-bis-(3,4-dihydroxyphenyl)-5-O-β-D-[6-(3,4-dimethoxycinnamoylglucopyranosyl)]-heptan-3-one (14). All of the diarylheptanoids, except 1 and 5, were found in A. glutinosa for the first time, while 13 and 14 were new compounds. The structures were determined by spectroscopic techniques: 1D and 2D NMR, HR-ESI-MS, FTIR, UV, and CD. All isolated compounds were analyzed for an in vitro protective effect on chromosome aberrations in peripheral human lymphocytes using the cytokinesis-block micronucleus assay. The majority of them, including the new compounds 13 and 14, exerted a pronounced effect in decreasing DNA damage in human lymphocytes. Diarylheptanoids 1, 2, 5, 13, and 14 at a concentration of 1 µg/mL decreased the frequency of micronuclei by 52.8 %, 43.8 %, 63.6 %, 44.4 %, and 56.0 %, respectively, exerting a much stronger effect than the synthetic protector amifostine (17.2 %, c = 1 µg/mL).
从桤木树皮中分离得到的次级代谢产物研究导致了 14 种二芳基庚烷类化合物的分离:奥瑞因(1)、扁柏双糖苷(2)、辣醇 A(3)、辣醇 B(4)、毛瑞诺酮(5)、毛瑞诺酮(6)、毛瑞诺酮-5-O-β-D-吡喃葡萄糖苷(7)、扁柏醇-5-O-β-D-木吡喃糖苷(8)、相思醇 VII(9)、桤木苷 A(10)、桤木苷 B(11)、1,7-双(3,4-二羟基苯基)-5-羟基-庚烷-3-O-β-D-吡喃木糖苷(12)、(5S)-1-(4-羟基苯基)-7-(3,4-二羟基苯基)-5-O-β-D-吡喃葡萄糖基-庚烷-3-酮(13)和(5S)-1,7-双(3,4-二羟基苯基)-5-O-β-D-[6-(3,4-二甲氧基肉桂酰基吡喃葡萄糖基)]-庚烷-3-酮(14)。除 1 和 5 外,所有的二芳基庚烷类化合物均首次在桤木中发现,而 13 和 14 是新化合物。结构通过光谱技术确定:1D 和 2D NMR、HR-ESI-MS、FTIR、UV 和 CD。所有分离得到的化合物均采用细胞有丝分裂阻断微核试验(cytokinesis-block micronucleus assay),分析其对人外周血淋巴细胞染色体畸变的体外保护作用。其中大多数化合物,包括新化合物 13 和 14,在降低人淋巴细胞 DNA 损伤方面表现出显著的效果。二芳基庚烷类化合物 1、2、5、13 和 14 在 1µg/mL 浓度下,微核频率分别降低了 52.8%、43.8%、63.6%、44.4%和 56.0%,比合成保护剂氨磷汀(17.2%,c=1µg/mL)的效果更强。